Evaluation of a novel diagnostic kit for detecting metastatic sentinel lymph nodes in breast cancer patients using the semi-dry dot blot method combined with an automatic reader: A single-center prospective study

Background: A semi-dry dot blot (SDB) detects lymph node (LN) metastases by measuring cytokeratin (CK) in LN lavage fluid using an anti-CK antibody. We evaluated a SDB kit that combines an anti-CK19 antibody with an automatic reader for the intraoperative diagnosis of LN metastasis in patients with breast cancer. This exploratory study evaluated the diagnostic performance and identified the optimal cut-off values for detection. Methods: We analyzed 226 LNs dissected from 108 breast cancer patients who underwent sentinel LN (SLN) biopsy at Nagasaki University Hospital between January and December 2020. The SDB kit assayed proteins extracted from SLNs and an automatic reader measured CK19 absorbance. The results were compared with those of hematoxylin and eosin staining and CK19 immunohistochemistry, interpreted independently and blindly by pathologists. Cut-off values for CK19 absorbance were determined post-hoc using receiver operating characteristic (ROC) curve analysis. Results: Among the 226 SLNs, histopathology identified 14 macrometastases (6.2%), 7 micrometastases (3.1%), and 205 metastasis-negative nodes, including one with isolated tumor cells (90.7%). Using a cut-off CK19 absorbance of 9.9 milli-absorbance units (mABS), sensitivity, specificity, and overall agreement of the SDB kit were 85.7%, 80.5%, and 81.0%, respectively. With a cut-off of 60.0 mABS to distinguish macrometastases from non-macrometastases, these values were 92.9%, 100%, and 99.6%, respectively. The assay required approximately 20 min, costing <$30 USD per test. Conclusions: This SDB kit combined with an automatic reader provided results quickly and accurately, with potentially lower implementation costs than pathologist-only diagnoses of metastases without LN tissue loss, permitting concurrent histopathology.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11420952/v1
Primary Topic
Breast Cancer Treatment Studies
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Evaluation of a novel diagnostic kit for detecting metastatic sentinel lymph nodes in breast cancer patients using the semi-dry dot blot method combined with an automatic reader: A single-center prospective study

Katsunori Yanagihara, Sayaka Kuba, Fujiko Kaseida, Rin Yamaguchi et al.
3 links
Research Square
Breast Cancer Treatment Studies
preprint

Evaluation of a novel diagnostic kit for detecting metastatic sentinel lymph nodes in breast cancer patients using the semi-dry dot blot method combined with an automatic reader: A single-center prospective study

Katsunori Yanagihara, Sayaka Kuba, Fujiko Kaseida, Rin Yamaguchi, Masahiro Nakashima, Yuko Akazawa, Momoko Akashi, Megumi Matsumoto, Aya Tanaka, Yuki Hara, Ryota Otsubo, Shintaro Urakawa, Keitaro Matsumoto
preprint en

Abstract

Background: A semi-dry dot blot (SDB) detects lymph node (LN) metastases by measuring cytokeratin (CK) in LN lavage fluid using an anti-CK antibody. We evaluated a SDB kit that combines an anti-CK19 antibody with an automatic reader for the intraoperative diagnosis of LN metastasis in patients with breast cancer. This exploratory study evaluated the diagnostic performance and identified the optimal cut-off values for detection. Methods: We analyzed 226 LNs dissected from 108 breast cancer patients who underwent sentinel LN (SLN) biopsy at Nagasaki University Hospital between January and December 2020. The SDB kit assayed proteins extracted from SLNs and an automatic reader measured CK19 absorbance. The results were compared with those of hematoxylin and eosin staining and CK19 immunohistochemistry, interpreted independently and blindly by pathologists. Cut-off values for CK19 absorbance were determined post-hoc using receiver operating characteristic (ROC) curve analysis. Results: Among the 226 SLNs, histopathology identified 14 macrometastases (6.2%), 7 micrometastases (3.1%), and 205 metastasis-negative nodes, including one with isolated tumor cells (90.7%). Using a cut-off CK19 absorbance of 9.9 milli-absorbance units (mABS), sensitivity, specificity, and overall agreement of the SDB kit were 85.7%, 80.5%, and 81.0%, respectively. With a cut-off of 60.0 mABS to distinguish macrometastases from non-macrometastases, these values were 92.9%, 100%, and 99.6%, respectively. The assay required approximately 20 min, costing <$30 USD per test. Conclusions: This SDB kit combined with an automatic reader provided results quickly and accurately, with potentially lower implementation costs than pathologist-only diagnoses of metastases without LN tissue loss, permitting concurrent histopathology.

Research Square
Nagasaki University (JP)
Good health and well-being
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon